{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:29:53Z","timestamp":1767983393888,"version":"3.49.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01323-z","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:46:03Z","timestamp":1737524763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Use of Bone Biomarkers, Imaging Tools, and Genetic Tests in the Diagnosis of Rare Bone Disorders"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-9702","authenticated-orcid":false,"given":"Farah","family":"Alsarraf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-5548","authenticated-orcid":false,"given":"Dalal S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"crossref","unstructured":"(2013) Report on the state of the art of rare disease activities in Europe; European Union Committee of Expert on Rare Disease. Overview of rare disease activities in Europe. Part I; pp 1\u201378. http:\/\/www.eucerd.eu\/upload\/file\/Reports\/2013ReportStateofArtRDActivities.pdf","DOI":"10.1186\/1750-1172-7-S2-A1"},{"issue":"12","key":"1323_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00103-007-0381-9","volume":"50","author":"S Aym\u00e9","year":"2007","unstructured":"Aym\u00e9 S, Schmidtke J (2007) Networking for rare diseases: a necessity for Europe. Bundesgesundh Gesundh Gesundh 50(12):1477\u20131483. https:\/\/doi.org\/10.1007\/s00103-007-0381-9","journal-title":"Bundesgesundh Gesundh Gesundh"},{"key":"1323_CR3","unstructured":"Available from: National Organization for Rare Diseases (NORD) of the United States: https:\/\/www.rarediseases.org. Accessed Jan 2015"},{"issue":"5","key":"1323_CR4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/ajmg.a.63132","volume":"191","author":"S Unger","year":"2023","unstructured":"Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, Cohn DH, Cormier-Daire V, Girisha KM, Hall C, Krakow D, Makitie O, Mundlos S, Nishimura G, Robertson SP, Savarirayan R, Sillence D, Simon M, Sutton VR et al (2023) Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A 191(5):1164\u20131209. https:\/\/doi.org\/10.1002\/ajmg.a.63132","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1323_CR5","first-page":"70","volume":"27","author":"N Peel","year":"2009","unstructured":"Peel N (2009) Bone remodelling and disorders of bone metabolism. Surg Infect (Larchmt) 27(2):70\u201374","journal-title":"Surg Infect (Larchmt)"},{"issue":"6","key":"1323_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0026-0495(77)90081-6","volume":"26","author":"T Lauffenburger","year":"1977","unstructured":"Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas HG (1977) Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget\u2019s Disease. Metab: Clin Exp 26(6):589\u2013606. https:\/\/doi.org\/10.1016\/0026-0495(77)90081-6","journal-title":"Metab: Clin Exp"},{"issue":"3","key":"1323_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ecl.2017.04.003","volume":"46","author":"CK Chew","year":"2017","unstructured":"Chew CK, Clarke BL (2017) Biochemical testing relevant to bone. Endocrinol Metab Clin North Am 46(3):649\u2013667. https:\/\/doi.org\/10.1016\/j.ecl.2017.04.003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"1323_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391\u2013420. https:\/\/doi.org\/10.1007\/s00198-010-1501-1","journal-title":"Osteoporos Int"},{"issue":"6","key":"1323_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s001980070002","volume":"11","author":"PD Delmas","year":"2000","unstructured":"Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11(6):S2\u2013S17. https:\/\/doi.org\/10.1007\/s001980070002","journal-title":"Osteoporos Int"},{"issue":"4","key":"1323_CR10","first-page":"97","volume":"26","author":"MJ Seibel","year":"2005","unstructured":"Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26(4):97\u2013122","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"1323_CR11","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1359\/jbmr.1999.14.5.792","volume":"14","author":"HW Woitge","year":"1999","unstructured":"Woitge HW, Pecherstorfer M, Li Y, Keck A, Horn E, Ziegler R, Seibel MJ (1999) Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14(5):792\u2013801. https:\/\/doi.org\/10.1359\/jbmr.1999.14.5.792","journal-title":"J Bone Miner Res"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/bonekey.2014.37","volume":"3","author":"PD Miller","year":"2014","unstructured":"Miller PD (2014) Chronic kidney disease and osteoporosis: evaluation and management. BoneKEy Rep 3:542\u2013542. https:\/\/doi.org\/10.1038\/bonekey.2014.37","journal-title":"BoneKEy Rep"},{"issue":"4","key":"1323_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","volume":"47","author":"P Garnero","year":"2001","unstructured":"Garnero P, Borel O, Delmas PD (2001) Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem (Baltimore Md) 47(4):694\u2013702. https:\/\/doi.org\/10.1093\/clinchem\/47.4.694","journal-title":"Clin Chem (Baltimore Md)"},{"key":"1323_CR14","unstructured":"Clinical and Laboratory Standards Institute (CLSI; Formerly NCCLS) (2001) Urinalysis and collection, transportation, and preservation of urine specimens; approved guideline, 2nd edn., vol 21, no. 19. Document GP-16A2. Wayne, PA"},{"issue":"4","key":"1323_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1210\/jc.77.4.1046","volume":"77","author":"P Garnero","year":"1993","unstructured":"Garnero P, Delmas PD (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77(4):1046\u20131053. https:\/\/doi.org\/10.1210\/jc.77.4.1046","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1323_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO","year":"2017","unstructured":"KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7(1):1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"1323_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/8756-3282(85)90326-6","volume":"6","author":"PD Delmas","year":"1985","unstructured":"Delmas PD, Malaval L, Arlot ME, Meunier PJ (1985) Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. Bone (NY) 6(5):339\u2013341. https:\/\/doi.org\/10.1016\/8756-3282(85)90326-6","journal-title":"Bone (NY)"},{"issue":"11","key":"1323_CR18","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","volume":"43","author":"JD Clemens","year":"1997","unstructured":"Clemens JD, Herrick MV, Singer FR, Eyre DR (1997) Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem (Baltimore, Md) 43(11):2058\u20132063. https:\/\/doi.org\/10.1093\/clinchem\/43.11.2058","journal-title":"Clin Chem (Baltimore, Md)"},{"issue":"10","key":"1323_CR19","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00198-015-3188-9","volume":"26","author":"L Masi","year":"2015","unstructured":"Masi L, Agnusdei D, Bilezikian J, Chappard D, Chapurlat R, Cianferotti L, Devolgelaer JP, El Maghraoui A, Ferrari S, Javaid MK, Kaufman JM, Liberman UA, Lyritis G, Miller P, Napoli N, Roldan E, Papapoulos S, Watts NB, Brandi ML (2015) Taxonomy of rare genetic metabolic bone disorders. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 26(10):2529\u20132558. https:\/\/doi.org\/10.1007\/s00198-015-3188-9","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bonr.2018.03.005","volume":"8","author":"A Bhan","year":"2018","unstructured":"Bhan A, Qiu S, Rao SD (2018) Bone histomorphometry in the evaluation of osteomalacia. Bone Rep 8:125\u2013134. https:\/\/doi.org\/10.1016\/j.bonr.2018.03.005","journal-title":"Bone Rep"},{"key":"1323_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bone.2016.07.020","volume":"102","author":"F Falardeau","year":"2017","unstructured":"Falardeau F, Camurri MV, Campeau PM (2017) Genomic approaches to diagnose rare bone disorders. Bone 102:5\u201314. https:\/\/doi.org\/10.1016\/j.bone.2016.07.020","journal-title":"Bone"},{"issue":"18","key":"1323_CR22","doi-asserted-by":"publisher","first-page":"13802","DOI":"10.3390\/ijms241813802","volume":"24","author":"N Aida","year":"2023","unstructured":"Aida N, Saito A, Azuma T (2023) Current status of next-generation sequencing in bone genetic diseases. Int J Mol Sci 24(18):13802. https:\/\/doi.org\/10.3390\/ijms241813802","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1323_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9","volume":"9","author":"H Kuivaniemi","year":"1997","unstructured":"Kuivaniemi H, Tromp G, Prockop DJ (1997) Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 9(4):300\u2013315. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(1997)9:4%3c300::AID-HUMU2%3e3.0.CO;2-9","journal-title":"Hum Mutat"},{"issue":"2","key":"1323_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16(2):101\u2013116. https:\/\/doi.org\/10.1136\/jmg.16.2.101","journal-title":"J Med Genet"},{"key":"1323_CR25","unstructured":"Online Mendelian Inheritance in Man (OMIM). https:\/\/www.omim.org\/"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0929-693X(08)71912-2","volume":"15","author":"G Baujat","year":"2008","unstructured":"Baujat G, Lebre AS, Cormier-Daire V et al (2008) Ost\u00e9ogen\u00e8se imparfaite, annonce du diagnostic (classification clinique et g\u00e9n\u00e9tique). Arch Pediatr 15:789\u2013791","journal-title":"Arch Pediatr"},{"issue":"6","key":"1323_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","volume":"34","author":"V Braga","year":"2004","unstructured":"Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone (NY) 34(6):1013\u20131016. https:\/\/doi.org\/10.1016\/j.bone.2004.02.023","journal-title":"Bone (NY)"},{"issue":"2","key":"1323_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s002239900670","volume":"65","author":"C Cepollaro","year":"1999","unstructured":"Cepollaro C, Gonnelli S, Pondrelli C, Montagnani A, Martini S, Bruni D, Gennari C (1999) Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters. Calcif Tissue Int 65(2):129\u2013132. https:\/\/doi.org\/10.1007\/s002239900670","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1323_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ejhg.2011.141","volume":"20","author":"FS van Dijk","year":"2012","unstructured":"van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, Rohrbach M, Symoens S, Sistermans EA, Pals G (2012) EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet: EJHG 20(1):11\u201319. https:\/\/doi.org\/10.1038\/ejhg.2011.141","journal-title":"Eur J Hum Genet: EJHG"},{"issue":"9418","key":"1323_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet (Br Ed) 363(9418):1377\u20131385. https:\/\/doi.org\/10.1016\/S0140-6736(04)16051-0","journal-title":"Lancet (Br Ed)"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3389\/fphar.2019.01200","volume":"10","author":"J Shi","year":"2019","unstructured":"Shi J, Ren M, Jia J, Tang M, Guo Y, Ni X, Shi T (2019) Genotype-phenotype association analysis reveals new pathogenic factors for osteogenesis imperfecta disease. Front Pharmacol 10:1200\u20131200. https:\/\/doi.org\/10.3389\/fphar.2019.01200","journal-title":"Front Pharmacol"},{"key":"1323_CR32","doi-asserted-by":"publisher","unstructured":"Tournis, S., & Dede, A. D. (2018). Osteogenesis imperfecta - A clinical update. Metabolism: clinical and experimental, 80, 27\u201337. https:\/\/doi.org\/10.1016\/j.metabol.2017.06.001","DOI":"10.1016\/j.metabol.2017.06.001"},{"issue":"4","key":"1323_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13244-013-0258-4","volume":"4","author":"A Renaud","year":"2013","unstructured":"Renaud A, Aucourt J, Weill J, Bigot J, Dieux A, Devisme L, Moraux A, Boutry N (2013) Radiographic features of osteogenesis imperfecta. Insights Imaging 4(4):417\u2013429. https:\/\/doi.org\/10.1007\/s13244-013-0258-4","journal-title":"Insights Imaging"},{"issue":"2","key":"1323_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5644\/ama2006-124.343","volume":"50","author":"JS Weaver","year":"2021","unstructured":"Weaver JS, Revels JW, Elifritz JM, Whitlow B, Retrouvey M, Wang SS (2021) Clinical manifestations and medical imaging of osteogenesis imperfecta: fetal through adulthood. Acta Med Acad 50(2):277\u2013291. https:\/\/doi.org\/10.5644\/ama2006-124.343","journal-title":"Acta Med Acad"},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"104926","DOI":"10.1016\/j.ejmg.2024.104926","volume":"68","author":"S Gazzotti","year":"2024","unstructured":"Gazzotti S, Sassi R, Aparisi G\u00f3mez MP, Moroni A, Brizola E, Miceli M, Bazzocchi A (2024) Imaging in osteogenesis imperfecta: Where we are and where we are going. Eur J Med Genet 68:104926\u2013104926. https:\/\/doi.org\/10.1016\/j.ejmg.2024.104926","journal-title":"Eur J Med Genet"},{"issue":"Suppl 2","key":"1323_CR36","first-page":"983","volume":"13","author":"LK Bachrach","year":"2000","unstructured":"Bachrach LK (2000) Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab: JPEM 13(Suppl 2):983\u2013988","journal-title":"J Pediatr Endocrinol Metab: JPEM"},{"issue":"1","key":"1323_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","volume":"4","author":"Z Stark","year":"2009","unstructured":"Stark Z, Savarirayan R (2009) Osteopetrosis. Orphanet J Rare Dis 4(1):5\u20135. https:\/\/doi.org\/10.1186\/1750-1172-4-5","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1323_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","volume":"84","author":"A Villa","year":"2009","unstructured":"Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C (2009) Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 84(1):1\u201312. https:\/\/doi.org\/10.1007\/s00223-008-9196-4","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1323_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","volume":"42","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore A, Cappariello A, Teti A (2008) Genetics, pathogenesis and complications of osteopetrosis. Bone (NY) 42(1):19\u201329. https:\/\/doi.org\/10.1016\/j.bone.2007.08.029","journal-title":"Bone (NY)"},{"issue":"1","key":"1323_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1749-6632.2009.05244.x","volume":"1192","author":"M-C de Vernejoul","year":"2010","unstructured":"de Vernejoul M-C, Kornak U (2010) Heritable sclerosing bone disorders: presentation and new molecular mechanisms. Ann N Y Acad Sci 1192(1):269\u2013277. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05244.x","journal-title":"Ann N Y Acad Sci"},{"key":"1323_CR41","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/genes13101880","volume":"13","author":"N Charoenngam","year":"2022","unstructured":"Charoenngam N, Nasr A, Shirvani A, Holick MF (2022) Hereditary metabolic bone diseases: a review of pathogenesis. Diagn Manag Genes 13:1880. https:\/\/doi.org\/10.3390\/genes13101880","journal-title":"Diagn Manag Genes"},{"issue":"4","key":"1323_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Del Fattore","year":"2006","unstructured":"Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H et al (2006) Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 43(4):315\u2013325. https:\/\/doi.org\/10.1136\/jmg.2005.036673","journal-title":"J Med Genet"},{"issue":"5","key":"1323_CR43","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1210\/jcem.87.5.8497","volume":"87","author":"SG Waguespack","year":"2002","unstructured":"Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ (2002) Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab 87(5):2212\u20132217. https:\/\/doi.org\/10.1210\/jcem.87.5.8497","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1323_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","volume":"50","author":"SL Alatalo","year":"2004","unstructured":"Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM (2004) Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers\u2013Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem (Baltimore, MD) 50(5):883\u2013890. https:\/\/doi.org\/10.1373\/clinchem.2003.029355","journal-title":"Clin Chem (Baltimore, MD)"},{"issue":"1","key":"1323_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<9::AID-AJMG4>3.0.CO;2-3","volume":"85","author":"I Takacs","year":"1999","unstructured":"Takacs I, Cooper H, Weaver DD, Econs MJ (1999) Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier. Am J Med Genet 85(1):9\u201312. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19990702)85:1%3c9::AID-AJMG4%3e3.0.CO;2-3","journal-title":"Am J Med Genet"},{"issue":"9","key":"1323_CR46","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2017-01127","volume":"102","author":"CC Wu","year":"2017","unstructured":"Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE (2017) Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab 102(9):3111\u20133123. https:\/\/doi.org\/10.1210\/jc.2017-01127","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1323_CR47","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1530\/EJE-13-0136","volume":"169","author":"J Bollerslev","year":"2013","unstructured":"Bollerslev J, Henriksen K, Nielsen MF, Brixen K, Van Hul W (2013) Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol 169(2):R39\u2013R57. https:\/\/doi.org\/10.1530\/EJE-13-0136","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1323_CR48","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","volume":"109","author":"S Dupuis-Girod","year":"2002","unstructured":"Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet J-C, Faivre L, Le Deist F, Durand P, D\u00f6ffinger R, Smahi A, Israel A, Courtois G, Brousse N, Blanche S, Munnich A, Fischer A, Casanova J-L, Bodemer C (2002) Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics (Evanston) 109(6):e97\u2013e97. https:\/\/doi.org\/10.1542\/peds.109.6.e97","journal-title":"Pediatrics (Evanston)"},{"issue":"3","key":"1323_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.2715","volume":"31","author":"M Arruda","year":"2016","unstructured":"Arruda M, Coelho MCA, Moraes AB, de Paula Paranhos-Neto F, Madeira M, Farias MLF, Neto LV (2016) Bone mineral density and microarchitecture in patients with autosomal dominant osteopetrosis: a report of two cases. J Bone Miner Res 31(3):657\u2013662. https:\/\/doi.org\/10.1002\/jbmr.2715","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1323_CR50","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/ajmg.a.32253","volume":"149A","author":"MA Faden","year":"2009","unstructured":"Faden MA, Krakow D, Ezgu F, Rimoin DL, Lachman RS (2009) The Erlenmeyer flask bone deformity in the skeletal dysplasias. Am J Med Genet A 149A(6):1334\u20131345. https:\/\/doi.org\/10.1002\/ajmg.a.32253","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1323_CR51","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-019-04921-y","volume":"30","author":"AA Khan","year":"2019","unstructured":"Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR (2019) Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 30(9):1713\u20131722. https:\/\/doi.org\/10.1007\/s00198-019-04921-y","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1323_CR52","unstructured":"Global Variome Shared LOVD ALPL (Alkaline Phosphatase, Liver\/Bone\/Kidney). https:\/\/databases.lovd.nl\/shared\/variants\/ALPL\/unique. Accessed 20 Sept 2022"},{"issue":"5","key":"1323_CR53","first-page":"767","volume":"47","author":"KN Fedde","year":"1990","unstructured":"Fedde KN, Whyte MP (1990) Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5\u2019-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet 47(5):767\u2013775","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1323_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","volume":"35","author":"AA Khan","year":"2024","unstructured":"Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A et al (2024) Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 35(3):431\u2013438. https:\/\/doi.org\/10.1007\/s00198-023-06844-1","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"12","key":"1323_CR55","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00198-021-06025-y","volume":"32","author":"L Seefried","year":"2021","unstructured":"Seefried L, Rak D, Petryk A, Genest F (2021) Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 32(12):2505\u20132513. https:\/\/doi.org\/10.1007\/s00198-021-06025-y","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"9","key":"1323_CR56","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","volume":"29","author":"L L\u00f3pez-Delgado","year":"2018","unstructured":"L\u00f3pez-Delgado L, Riancho-Zarrabeitia L, Garc\u00eda-Unzueta MT, Tenorio JA, Garc\u00eda-Hoyos M, Lapunzina P, Valero C, Riancho JA (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 29(9):2147\u20132150. https:\/\/doi.org\/10.1007\/s00198-018-4571-0","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1323_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone 102:15\u201325. https:\/\/doi.org\/10.1016\/j.bone.2017.02.011","journal-title":"Bone"},{"key":"1323_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.177","author":"E Mornet","year":"2014","unstructured":"Mornet E, Hofmann C, Bloch-Zupan A, Girschick H, LeMerrer M (2014) Clinical utility gene card for: hypophosphatasia\u2014update 2013. Eur J Hum Genet: EJHG. https:\/\/doi.org\/10.1038\/ejhg.2013.177","journal-title":"Eur J Hum Genet: EJHG"},{"issue":"12","key":"1323_CR59","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00198-015-3272-1","volume":"26","author":"ML Bianchi","year":"2015","unstructured":"Bianchi ML (2015) Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA 26(12):2743\u20132757. https:\/\/doi.org\/10.1007\/s00198-015-3272-1","journal-title":"Osteoporos Int: J Establ Result Cooper Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"1323_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bone.2016.10.022","volume":"94","author":"B Mentrup","year":"2017","unstructured":"Mentrup B, Girschick H, Jakob F, Hofmann C (2017) A homozygous intronic branch-point deletion in the ALPL gene causes infantile hypophosphatasia. Bone 94:75\u201383. https:\/\/doi.org\/10.1016\/j.bone.2016.10.022","journal-title":"Bone"},{"issue":"6","key":"1323_CR61","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res: Offic J Am Soc Bone Miner Res 24(6):1132\u20131134. https:\/\/doi.org\/10.1359\/jbmr.081253","journal-title":"J Bone Miner Res: Offic J Am Soc Bone Miner Res"},{"issue":"5","key":"1323_CR62","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38(5):525\u2013527. https:\/\/doi.org\/10.1038\/ng1783","journal-title":"Nat Genet"},{"key":"1323_CR63","unstructured":"Akesson LS, Savarirayan R (2020) Fibrodysplasia Ossificans Progressiva. 2020 Jun 11 [Updated 2023 May 11]. In: Adam MP, Feldman J, Mirzaa GM, et al. (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle, pp 1993\u20132024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558090\/"},{"issue":"1","key":"1323_CR64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1302\/0301-620x.64b1.7068725","volume":"64","author":"JM Connor","year":"1982","unstructured":"Connor JM, Evans DA (1982) Fibrodysplasia ossificans progressive. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64(1):76\u201383. https:\/\/doi.org\/10.1302\/0301-620x.64b1.7068725","journal-title":"J Bone Joint Surg Br"},{"issue":"2","key":"1323_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2106\/00004623-199302000-00008","volume":"75","author":"RB Cohen","year":"1993","unstructured":"Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, Sando A, Sando N, Zasloff M, Kaplan FS (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressive. A study of forty-four patients. J Bone Joint Surg Am 75(2):215\u2013219. https:\/\/doi.org\/10.2106\/00004623-199302000-00008","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"1323_CR66","first-page":"437","volume":"10","author":"RJ Pignolo","year":"2013","unstructured":"Pignolo RJ, Shore EM, Kaplan FS (2013) Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev 10(2):437\u2013448 (PMID: 23858627; PMCID: PMC3995352)","journal-title":"Pediatr Endocrinol Rev"},{"issue":"8","key":"1323_CR67","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/genes12081187","volume":"12","author":"D De Brasi","year":"2021","unstructured":"De Brasi D, Orlando F, Gaeta V, De Liso M, Acquaviva F, Martemucci L, Mastrominico A, DiRocco M (2021) Fibrodysplasia ossificans progressiva: a challenging diagnosis. Genes 12(8):1187. https:\/\/doi.org\/10.3390\/genes12081187","journal-title":"Genes"},{"issue":"10","key":"1323_CR68","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ejhg.2014.274","volume":"23","author":"N Bravenboer","year":"2015","unstructured":"Bravenboer N, Micha D, Triffit JT, Bullock AN, Ravazollo R, Bocciardi R, di Rocco M, Netelenbos JC, Ten Dijke P, S\u00e1nchez-Duffhues G, Kaplan FS, Shore EM, Pignolo RJ, Seemann P, Ventura F, Beaujat G, Eekhoff EMW, Pals G (2015) Clinical utility gene card for: fibrodysplasia ossificans progressiva. Eur J Hum Genet: EJHG 23(10):1431\u20131431. https:\/\/doi.org\/10.1038\/ejhg.2014.274","journal-title":"Eur J Hum Genet: EJHG"},{"issue":"2","key":"1323_CR69","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2013.09.002","volume":"57","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zhang K, Song L, Pang J, Ma H, Shore EM, Kaplan FS, Wang P (2013) The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases. Bone (New York) 57(2):386\u2013391. https:\/\/doi.org\/10.1016\/j.bone.2013.09.002","journal-title":"Bone (New York)"},{"issue":"5","key":"1323_CR70","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1542\/peds.2007-1980","volume":"121","author":"FS Kaplan","year":"2008","unstructured":"Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore EM (2008) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics (Evanston) 121(5):e1295\u2013e1300. https:\/\/doi.org\/10.1542\/peds.2007-1980","journal-title":"Pediatrics (Evanston)"},{"issue":"5","key":"1323_CR71","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1542\/peds.2005-0469","volume":"116","author":"JA Kitterman","year":"2005","unstructured":"Kitterman JA, Kantanie S, Rocke DM, Kaplan FS (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics (Evanston) 116(5):e654\u2013e661. https:\/\/doi.org\/10.1542\/peds.2005-0469","journal-title":"Pediatrics (Evanston)"},{"key":"1323_CR72","first-page":"1","volume":"2","author":"FS Kaplan","year":"2022","unstructured":"Kaplan FS et al (2022) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Proc Intl Clin Council FOP 2:1\u2013127","journal-title":"Proc Intl Clin Council FOP"},{"key":"1323_CR73","doi-asserted-by":"publisher","unstructured":"Kaplan FS, Pignolo RJ, Al Mukaddam M, Shore EM (2018) Genetic disorders of heterotopic ossification. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley, pp 865\u2013870. https:\/\/doi.org\/10.1002\/9781119266594.ch112","DOI":"10.1002\/9781119266594.ch112"},{"issue":"3","key":"1323_CR74","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","volume":"31","author":"RJ Pignolo","year":"2016","unstructured":"Pignolo RJ, Bedford-Gay C, Liljesthr\u00f6m M, Durbin-Johnson BP, Shore EM, Rocke DM, Kaplan FS (2016) The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment. J Bone Miner Res 31(3):650\u2013656. https:\/\/doi.org\/10.1002\/jbmr.2728","journal-title":"J Bone Miner Res"},{"key":"1323_CR75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bone.2017.08.011","volume":"109","author":"M Al Mukaddam","year":"2018","unstructured":"Al Mukaddam M, Rajapakse CS, Pignolo RJ, Kaplan FS, Smith SE (2018) Imaging assessment of fibrodysplasia ossificans progressiva: qualitative, quantitative and questionable. Bone (New York) 109:147\u2013152. https:\/\/doi.org\/10.1016\/j.bone.2017.08.011","journal-title":"Bone (New York)"},{"issue":"5","key":"1323_CR76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s002470100447","volume":"31","author":"S Mahboubi","year":"2001","unstructured":"Mahboubi S, Glaser DL, Shore EM, Kaplan FS (2001) Fibrodysplasia ossificans progressiva. Pediatr Radiol 31(5):307\u2013314. https:\/\/doi.org\/10.1007\/s002470100447","journal-title":"Pediatr Radiol"},{"issue":"6","key":"1323_CR77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00223-021-00877-6","volume":"109","author":"SE Warner","year":"2021","unstructured":"Warner SE, Kaplan FS, Pignolo RJ, Smith SE, Hsiao EC, De Cunto C, Di Rocco M, Harnett K, Grogan D, Genant HK (2021) Whole-body computed tomography versus dual energy X-ray absorptiometry for assessing heterotopic ossification in fibrodysplasia ossificans progressiva. Calcif Tissue Int 109(6):615\u2013625. https:\/\/doi.org\/10.1007\/s00223-021-00877-6","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1323_CR78","doi-asserted-by":"publisher","first-page":"e10363","DOI":"10.1002\/jbm4.10363","volume":"4","author":"E Botman","year":"2020","unstructured":"Botman E, Teunissen BP, Raijmakers P, Graaf P, Yaqub M, Treurniet S, Schoenmaker T, Bravenboer N, Micha D, Pals G, B\u00f6kenkamp A, Netelenbos JC, Lammertsma AA, Eekhoff EM (2020) Diagnostic value of magnetic resonance imaging in fibrodysplasia ossificans progressiva. JBMR Plus 4(6):e10363. https:\/\/doi.org\/10.1002\/jbm4.10363","journal-title":"JBMR Plus"},{"issue":"Suppl 2","key":"1323_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000058106","volume":"57","author":"E Schoenau","year":"2002","unstructured":"Schoenau E, Rauch F (2002) Fibrous dysplasia. Hormone Res 57(Suppl 2):79\u201382. https:\/\/doi.org\/10.1159\/000058106","journal-title":"Hormone Res"},{"issue":"24","key":"1323_CR80","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the Mccune\u2013Albright syndrome. N Engl J Med 325(24):1688\u20131695. https:\/\/doi.org\/10.1056\/NEJM199112123252403","journal-title":"N Engl J Med"},{"issue":"8","key":"1323_CR81","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2106\/00004623-200508000-00028","volume":"87","author":"MR Dicaprio","year":"2005","unstructured":"Dicaprio MR, Enneking WF (2005) Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 87(8):1848\u20131864. https:\/\/doi.org\/10.2106\/00004623-200508000-00028","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"1323_CR82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","volume":"22","author":"RD Chapurlat","year":"2008","unstructured":"Chapurlat RD, Orcel P (2008) Fibrous dysplasia of bone and McCune\u2013Albright syndrome. Best Pract Res Clin Rheumatol 22(1):55\u201369. https:\/\/doi.org\/10.1016\/j.berh.2007.11.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1323_CR83","first-page":"743","volume":"52","author":"DJ McCune","year":"1936","unstructured":"McCune DJ (1936) Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743\u2013744","journal-title":"Am J Dis Child"},{"issue":"17","key":"1323_CR84","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJM193704292161701","volume":"216","author":"F Albright","year":"1937","unstructured":"Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N Engl J Med 216(17):727\u2013746. https:\/\/doi.org\/10.1056\/NEJM193704292161701","journal-title":"N Engl J Med"},{"issue":"3","key":"1323_CR85","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/thy.1997.7.433","volume":"7","author":"G Mastorakos","year":"1997","unstructured":"Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA (1997) Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid: Off J Am Thyroid Assoc 7(3):433\u2013439. https:\/\/doi.org\/10.1089\/thy.1997.7.433","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"issue":"11","key":"1323_CR86","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1210\/jc.2001-012022","volume":"87","author":"SO Akintoye","year":"2002","unstructured":"Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87(11):5104\u20135112. https:\/\/doi.org\/10.1210\/jc.2001-012022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1323_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","volume":"14","author":"MK Javaid","year":"2019","unstructured":"Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard A-M, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R et al (2019) Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium. Orphanet J Rare Dis 14(1):139\u2013139. https:\/\/doi.org\/10.1186\/s13023-019-1102-9","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1323_CR88","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","volume":"73","author":"P Ruggieri","year":"1994","unstructured":"Ruggieri P, Sim FH, Bond JR, Krishnan Unni K (1994) Malignancies in fibrous dysplasia. Cancer 73(5):1411\u20131424. https:\/\/doi.org\/10.1002\/1097-0142(19940301)73:5%3c1411::AID-CNCR2820730516%3e3.0.CO;2-T","journal-title":"Cancer"},{"issue":"4","key":"1323_CR89","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00402-008-0669-8","volume":"129","author":"B Doganavsargil","year":"2009","unstructured":"Doganavsargil B, Argin M, Kececi B, Sezak M, Sanli UA, Oztop F (2009) Secondary osteosarcoma arising in fibrous dysplasia, case report. Arch Orthop Trauma Surg 129(4):439\u2013444. https:\/\/doi.org\/10.1007\/s00402-008-0669-8","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"1323_CR90","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5858\/arpa.2012.0013-RS","volume":"137","author":"ND Riddle","year":"2013","unstructured":"Riddle ND, Bui MM (2013) Fibrous dysplasia. Arch Pathol Lab Med (1976) 137(1):134\u2013138. https:\/\/doi.org\/10.5858\/arpa.2012.0013-RS","journal-title":"Arch Pathol Lab Med (1976)"},{"key":"1323_CR91","doi-asserted-by":"publisher","first-page":"116744","DOI":"10.1016\/j.bone.2023.116744","volume":"171","author":"ME Meier","year":"2023","unstructured":"Meier ME, Hagelstein-Rotman M, Streefland TCM, Winter EM, Bravenboer N, Appelman-Dijkstra NM (2023) Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia\/McCune\u2013Albright syndrome. Bone (New York) 171:116744\u2013116744. https:\/\/doi.org\/10.1016\/j.bone.2023.116744","journal-title":"Bone (New York)"},{"issue":"4","key":"1323_CR92","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jbmr.3649","volume":"34","author":"P Florenzano","year":"2019","unstructured":"Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM (2019) Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res 34(4):653\u2013660. https:\/\/doi.org\/10.1002\/jbmr.3649","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1323_CR93","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbmr.3602","volume":"34","author":"LF de Castro","year":"2019","unstructured":"de Castro LF, Burke AB, Wang HD, Tsai J, Florenzano P, Pan KS, Bhattacharyya N, Boyce AM, Gafni RI, Molinolo AA, Robey PG, Collins MT (2019) Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden. J Bone Miner Res 34(2):290\u2013294. https:\/\/doi.org\/10.1002\/jbmr.3602","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1323_CR94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/01.bpb.0000064021.41829.94","volume":"12","author":"E Ippolito","year":"2003","unstructured":"Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P, European Pediatric Orthopaedic Society (2003) Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthoped. Part B 12(3):155\u2013177. https:\/\/doi.org\/10.1097\/01.bpb.0000064021.41829.94","journal-title":"J Pediatr Orthoped. Part B"},{"issue":"6","key":"1323_CR95","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2559.2007.02676.x","volume":"50","author":"BD Idowu","year":"2007","unstructured":"Idowu BD, Al-Adnani M, O\u2019Donnell P, Yu L, Odell E, Diss T, Gale RE, Flanagan AM (2007) A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology 50(6):691\u2013704. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02676.x","journal-title":"Histopathology"},{"key":"1323_CR96","unstructured":"Szymczuk V, Florenzano P, de Castro LF, Collins MT, Boyce AM (2015) Fibrous dysplasia\/McCune\u2013Albright syndrome. 2015 Feb 26 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle, pp 1993\u20132024. PMID: 25719192"},{"key":"1323_CR97","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpeds.2018.09.070","volume":"205","author":"P Romanet","year":"2019","unstructured":"Romanet P, Philibert P, Fina F, Cuny T, Roche C, Ouafik L, Paris F, Reynaud R, Barlier A (2019) Using digital droplet polymerase chain reaction to detect the mosaic GNAS mutations in whole blood DNA or circulating cell-free DNA in fibrous dysplasia and McCune\u2013Albright syndrome. J Pediatr 205:281-285.e4. https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.070","journal-title":"J Pediatr"},{"issue":"3","key":"1323_CR98","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jbmr.4766","volume":"38","author":"KL Roszko","year":"2023","unstructured":"Roszko KL, Guthrie L, Li X, Collins MT, de Castro LF, Boyce AM (2023) Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia\/McCune Albright syndrome. J Bone Miner Res: Off J Am Soc Bone Miner Res 38(3):443\u2013450. https:\/\/doi.org\/10.1002\/jbmr.4766","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"issue":"11","key":"1323_CR99","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1359\/jbmr.080609","volume":"23","author":"SA Kuznetsov","year":"2008","unstructured":"Kuznetsov SA, Cherman N, Riminucci M, Collins MT, Robey PG, Bianco P (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone. J Bone Miner Res 23(11):1731\u20131740. https:\/\/doi.org\/10.1359\/jbmr.080609","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1323_CR100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.rlu.0000113856.7","volume":"29","author":"Y Zhibin","year":"2004","unstructured":"Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z (2004) The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med 29(3):177\u2013180. https:\/\/doi.org\/10.1097\/01.rlu.0000113856.7","journal-title":"Clin Nucl Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01323-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:21:17Z","timestamp":1766755277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01323-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01323-z","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MLB has received honoraria from Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, and UCB; grants and\/or speaker for Abiogen, Alexion, Amgen, Bruno Farmaceutici, Echolight, Eli Lilly, Kyowa Kirin, SPA, Theramex, and UCB; Consultant for Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, and UCB. MLB is also a guest editor of Calcified Tissue International. FA and DSA declare that they have no conflict of interest. The authors have no financial or proprietary interests in any material discussed in this article. The authors have no personal, financial, or institutional interest and ethical\/legal conflicts involved in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study used only publicly available data so that no additional ethical approval was required. Details of ethical approval and participant consent for each study that contributed to GWAS can be found in the original publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Each author has given her consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All data were derived from published studies or publicly available GWAS abstract data in which ethical approval and informed consent were provided. No separate ethical approval was required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Human and Animal Rights"}}],"article-number":"32"}}